Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
55.63
-0.44 (-0.78%)
At close: Jun 02, 2025, 3:59 PM
55.42
-0.37%
After-hours: Jun 02, 2025, 07:41 PM EDT
Halozyme Therapeutics Revenue
Halozyme Therapeutics reported an annual revenue of $1.02B, reflecting a 22.44% growth. For the quarter ending March 31, 2025, Halozyme Therapeutics generated $264.86M in revenue.
Revenue (ttm)
$1.02B
Revenue Growth
22.44%
Price / Sales Ratio
5.97
Revenue / Employee
$2.9M
Employees
350
Market Cap
6.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|